Overview
Terminal extramedullary conus spinal cord lipoma is a rare congenital spinal dysraphism characterized by a lipomatous (fatty) mass located at the terminal end of the spinal cord (conus medullaris) but situated outside the medullary tissue itself. Unlike intradural lipomas that infiltrate the substance of the spinal cord, this type of lipoma is attached to the terminal conus or filum terminale without significant invasion into the neural tissue. It is classified among closed spinal dysraphisms (occult spinal dysraphisms), meaning the overlying skin is typically intact, though cutaneous stigmata such as a subcutaneous lipoma, skin dimple, or hairy patch may be present over the lower back. This condition primarily affects the nervous system, specifically the lumbosacral spinal cord and associated nerve roots. The lipoma can cause tethering of the spinal cord, restricting its normal movement within the spinal canal. As a child grows, this tethering may lead to progressive neurological symptoms including lower extremity weakness, gait abnormalities, sensory changes in the legs and perineal region, back or leg pain, and bladder or bowel dysfunction (neurogenic bladder or bowel). Orthopedic manifestations such as foot deformities (e.g., pes cavus, equinovarus) or scoliosis may also develop. Symptoms may present in infancy or childhood, though some patients remain asymptomatic until later in life. Diagnosis is typically made through magnetic resonance imaging (MRI) of the spine, which can delineate the lipoma and its relationship to the conus medullaris and surrounding neural structures. Management depends on the presence and severity of symptoms. Surgical intervention, usually involving untethering of the spinal cord and debulking of the lipoma, is considered when neurological deterioration is evident or anticipated. The goal of surgery is to prevent further neurological decline rather than to reverse existing deficits. Prophylactic surgery in asymptomatic patients remains a topic of clinical debate. Long-term urological and neurological follow-up is recommended, as retethering can occur after surgical intervention.
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Terminal extramedullary conus spinal cord lipoma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Terminal extramedullary conus spinal cord lipoma at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Terminal extramedullary conus spinal cord lipoma.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Terminal extramedullary conus spinal cord lipoma.
Community
No community posts yet. Be the first to share your experience with Terminal extramedullary conus spinal cord lipoma.
Start the conversation →Latest news about Terminal extramedullary conus spinal cord lipoma
No recent news articles for Terminal extramedullary conus spinal cord lipoma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Terminal extramedullary conus spinal cord lipoma
What is Terminal extramedullary conus spinal cord lipoma?
Terminal extramedullary conus spinal cord lipoma is a rare congenital spinal dysraphism characterized by a lipomatous (fatty) mass located at the terminal end of the spinal cord (conus medullaris) but situated outside the medullary tissue itself. Unlike intradural lipomas that infiltrate the substance of the spinal cord, this type of lipoma is attached to the terminal conus or filum terminale without significant invasion into the neural tissue. It is classified among closed spinal dysraphisms (occult spinal dysraphisms), meaning the overlying skin is typically intact, though cutaneous stigmata
How is Terminal extramedullary conus spinal cord lipoma inherited?
Terminal extramedullary conus spinal cord lipoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.